cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Penumbra Inc
74 own
9 watching
Current Price
$0
$-0.65
(-0.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10,068.81M
52-Week High
52-Week High
266.63
52-Week Low
52-Week Low
114.865
Average Volume
Average Volume
0.03M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
1123.46
iconMarket Capitalization10,068.81M
icon52-Week High266.63
icon52-Week Low114.865
iconAverage Volume0.03M
iconDividend Yield--
iconP/E Ratio1123.46
What does the Penumbra Inc do?
Markets devices for neuro and peripheral vascular conditions and diseases.
Read More
How much money does Penumbra Inc make?
News & Events about Penumbra Inc.
Zolmax
1month ago
Penumbra (NYSE:PEN Get Rating) had its price target raised by Truist Financial from $228.00 to $255.00 in a report published on Tuesday , Benzinga reports. Truist Financial currently has a buy rating on the stock. Other research analysts have also recently issued research reports about the company. ...
Globe Newswire
3 months ago
SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology, the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara Nelson and Surbhi Sarna to its board of directors. Both appointees are visionaries across the biotech, ...
Benzinga
4 months ago
Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter: Latest Ratings for PEN DateFirmActionFromTo Mar 2022NeedhamInitiates Coverage OnHold Feb 2022CitigroupMaintainsBuy Feb 2022JP MorganMaintainsOverweight View More Analyst Ratings for PEN View the ...
Business Wire
4 months ago
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, and Asahi Intecc Co., a leading Japanese medical device manufacturer, announced that they will collaborate to introduce Penumbras Indigo Aspiration System into the Japanese market upon regulatory approval. This...
Business Wire
4 months ago
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that its RED Reperfusion Catheters have secured CE Mark (Conformit Europenne) and are now commercially available in Europe. The catheters are part of the companys Penumbra System, which is a fully...
Frequently Asked Questions
Frequently Asked Questions
What is Penumbra Inc share price today?
plus_minus_icon
Can Indians buy Penumbra Inc shares?
plus_minus_icon
How can I buy Penumbra Inc shares from India?
plus_minus_icon
Can Fractional shares of Penumbra Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Penumbra Inc stocks?
plus_minus_icon
What is today’s traded volume of Penumbra Inc?
plus_minus_icon
What is today’s market capitalisation of Penumbra Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Penumbra Inc?
plus_minus_icon
What percentage is Penumbra Inc down from its 52-Week High?
plus_minus_icon
What percentage is Penumbra Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.65
(-0.25%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00